ATYR
Price
$5.49
Change
+$0.25 (+4.77%)
Updated
Aug 11, 11:58 AM (EDT)
Capitalization
471.72M
87 days until earnings call
RZLT
Price
$5.81
Change
+$0.24 (+4.31%)
Updated
Aug 8 closing price
Capitalization
505.45M
31 days until earnings call
Interact to see
Advertisement

ATYR vs RZLT

Header iconATYR vs RZLT Comparison
Open Charts ATYR vs RZLTBanner chart's image
aTyr Pharma
Price$5.49
Change+$0.25 (+4.77%)
Volume$1.7K
Capitalization471.72M
Rezolute
Price$5.81
Change+$0.24 (+4.31%)
Volume$420.65K
Capitalization505.45M
ATYR vs RZLT Comparison Chart in %
Loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. RZLT commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a Hold and RZLT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (ATYR: $5.24 vs. RZLT: $5.81)
Brand notoriety: ATYR and RZLT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 1% vs. RZLT: 38%
Market capitalization -- ATYR: $471.72M vs. RZLT: $505.45M
ATYR [@Biotechnology] is valued at $471.72M. RZLT’s [@Biotechnology] market capitalization is $505.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileRZLT’s FA Score has 0 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • RZLT’s FA Score: 0 green, 5 red.
According to our system of comparison, RZLT is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 3 TA indicator(s) are bullish while RZLT’s TA Score has 4 bullish TA indicator(s).

  • ATYR’s TA Score: 3 bullish, 7 bearish.
  • RZLT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RZLT is a better buy in the short-term than ATYR.

Price Growth

ATYR (@Biotechnology) experienced а +11.49% price change this week, while RZLT (@Biotechnology) price change was -1.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.35%. For the same industry, the average monthly price growth was +31.87%, and the average quarterly price growth was +19.42%.

Reported Earning Dates

ATYR is expected to report earnings on Nov 06, 2025.

RZLT is expected to report earnings on Sep 11, 2025.

Industries' Descriptions

@Biotechnology (+22.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RZLT($505M) has a higher market cap than ATYR($472M). ATYR YTD gains are higher at: 44.751 vs. RZLT (18.571). ATYR has higher annual earnings (EBITDA): -65.9M vs. RZLT (-77.12M). RZLT has more cash in the bank: 86.9M vs. ATYR (76.3M). RZLT has less debt than ATYR: RZLT (1.78M) vs ATYR (13M). ATYR (0) and RZLT (0) have equivalent revenues.
ATYRRZLTATYR / RZLT
Capitalization472M505M93%
EBITDA-65.9M-77.12M85%
Gain YTD44.75118.571241%
P/E RatioN/AN/A-
Revenue00-
Total Cash76.3M86.9M88%
Total Debt13M1.78M732%
FUNDAMENTALS RATINGS
ATYR vs RZLT: Fundamental Ratings
ATYR
RZLT
OUTLOOK RATING
1..100
5057
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3739
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RZLT's Valuation (52) in the null industry is in the same range as ATYR (83). This means that RZLT’s stock grew similarly to ATYR’s over the last 12 months.

RZLT's Profit vs Risk Rating (100) in the null industry is in the same range as ATYR (100). This means that RZLT’s stock grew similarly to ATYR’s over the last 12 months.

RZLT's SMR Rating (98) in the null industry is in the same range as ATYR (100). This means that RZLT’s stock grew similarly to ATYR’s over the last 12 months.

ATYR's Price Growth Rating (37) in the null industry is in the same range as RZLT (39). This means that ATYR’s stock grew similarly to RZLT’s over the last 12 months.

ATYR's P/E Growth Rating (100) in the null industry is in the same range as RZLT (100). This means that ATYR’s stock grew similarly to RZLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATYRRZLT
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 15 days ago
88%
Declines
ODDS (%)
Bearish Trend 11 days ago
83%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RZLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGIQX16.190.22
+1.38%
Macquarie Growth and Income R6
RYVIX190.001.22
+0.65%
Rydex Energy Services Inv
HDSIX21.600.11
+0.51%
Hodges Small Cap Grwoth Institutional
CSECX33.980.11
+0.32%
Calvert Equity C
GMXAX15.92N/A
N/A
Nationwide Mid Cap Market Idx A

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with MGTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
N/A
MGTX - ATYR
42%
Loosely correlated
+3.41%
RZLT - ATYR
41%
Loosely correlated
+4.31%
AMLX - ATYR
41%
Loosely correlated
-2.55%
SLDB - ATYR
40%
Loosely correlated
+1.62%
IDYA - ATYR
40%
Loosely correlated
+3.08%
More

RZLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RZLT has been loosely correlated with RLAY. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RZLT jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RZLT
1D Price
Change %
RZLT100%
+4.31%
RLAY - RZLT
47%
Loosely correlated
-7.74%
XNCR - RZLT
45%
Loosely correlated
-1.23%
ATYR - RZLT
42%
Loosely correlated
N/A
SYRE - RZLT
41%
Loosely correlated
N/A
SMMT - RZLT
40%
Loosely correlated
+2.10%
More